[ad_1]
Lupin Limited has introduced the launch of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Resolution, 17.5 g/3.13 g/1.6 g per 6 ounces, having acquired an approval from the USA Meals and Drug Administration (USFDA).
As per the pregulatory submitting, Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Resolution, 17.5 g/3.13 g/1.6 g per 6 ounces is a generic equal of Suprep Bowel Prep Equipment Oral Resolution, 17.5 g/3.13 g/1.6 g per 6 ounces, of Braintree Laboratories Inc.
In keeping with the IQVIA MAT July 2022, Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Resolution (RLD Suprep Bowel Prep Equipment) had estimated annual gross sales of USD 202 million within the U.S.
At round 3:15 PM, Lupin Ltd is at present buying and selling at Rs669.80 per share up by Rs3.05 or 0.46% from its earlier closing of Rs666.75 per share on the BSE.
For suggestions and ideas, write to us at [email protected]
[ad_2]
Source link